Clinical Trial Update: Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating lenalidomide maintenance therapy in patients with myelodysplastic syndromes or acute myeloid leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Myelodysplastic Syndromes, Acute Myelogenous Leukemia | Phase 2 | Status: TERMINATED